Forward Citations = 0

Loading Chart...

11 inventors (with patents filed for the assignee):

Teit E Johansen (4 out of 16 patents)

Lars Ulrik Wahlberg (3 out of 16 patents)

Jesper Roland Jorgensen (3 out of 5 patents)

4. Lone Fjord-Larsen (2 out of 4 patents)

5. Nuno Miguel Gomes Andrade (2 out of 4 patents)

6. Philip Kusk (1 out of 7 patents)

7. Mette Grønborg (1 out of 1 patent)

8. Nikolaj Blom (1 out of 3 patents)

9. Thomas Nordahl Petersen (1 out of 1 patent)

10. Søren Brunak (1 out of 1 patent)

11. Lars U Wahlberg (1 out of 7 patents)

4 patents: Sort by Forward Citations

1. 10034918 - Therapeutic use of a growth factor, METRNL (2018-07-31),

2. 9861682 - Treatment of hyperalgesia, spontaneous pain, and phantom pain (2018-01-09),

3. 9845344 - Therapeutic use of a growth factor, NsG33 (2017-12-19),

4. 9675669 - Therapeutic use of a growth factor, METRNL (2017-06-13),

Company Overview

Hoba Therapeutics Aps is a biotechnology company dedicated to developing innovative treatments for rare genetic diseases. With a focus on gene therapy and personalized medicine, Hoba Therapeutics aims to address unmet medical needs and improve the quality of life for patients around the world.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#67 in Copenhagen

#551 in Denmark

Copenhagen, Denmark

Hoba Therapeutics Aps

Forward Citations = 0

11 inventors:

Teit E Johansen (4 out of 16 patents)

Lars Ulrik Wahlberg (3 out of 16 patents)

Jesper Roland Jorgensen (3 out of 5 patents)

4. Lone Fjord-Larsen (2 out of 4 patents)

5. Nuno Miguel Gomes Andrade (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hoba Therapeutics Aps. Retrieved from https://idiyas.com/company/hoba-therapeutics-aps

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]